Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antibodies selective for cells presenting EGFR at high density

Antibodies selective for cells presenting EGFR at high density

US Patent 10570211 · Granted Feb 25, 2020

Estimated economic value: $536,909,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Engineered TGF-beta monomers and their use for inhibiting TGF-beta signaling2025
Activin receptor type IIB variants and uses thereof2025
Anti-G-CSF antibodies and uses thereof2025
Anti-G-CSF antibodies and uses thereof2025
TGF-β-receptor ectodomain fusion molecules and uses thereof2025
TGF-β-receptor ectodomain fusion molecules and uses thereof2025
Antibody variants with pH-dependent antigen binding for selective targeting of s2025
Antibody variants with pH-dependent antigen binding for selective targeting of s2025
Antibody variants with pH-dependent antigen binding for selective targeting of s2025
Antibodies selective for cells presenting EGFR at high density2024
Antibodies selective for cells presenting EGFR at high density2024
Antibodies selective for cells presenting EGFR at high density2024